Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53.
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also the author of the Health Care Inc. newsletter. You can reach Bob on Signal at bobjherman.09.
A federal watchdog found that Medicare Advantage insurers led by UnitedHealth Group collected billions of dollars in dubious payments from Medicare by using home visits and medical chart reviews to diagnose patients with conditions for which they received no follow-up care.
Insurers collectively received an estimated $7.5 billion in payments last year from health risk assessments (HRAs) and related reviews of medical records performed in 2022, a report released Thursday by the Office of Inspector General for the Health and Human Services Department concluded. The diagnoses added during those assessments were not found in any of the patients’ other medical records that year, suggesting that they were either inaccurate or that patients did not get potentially necessary care for serious conditions, the report found.
advertisement
A single company — UnitedHealth Group — accounted for $3.7 billion of the questionable payments, or almost half of the total. The findings mirror an investigation by STAT that found UnitedHealth used its unrivaled network of physicians to pack patients’ charts with diagnoses to reap larger payments from Medicare.
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53.
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also the author of the Health Care Inc. newsletter. You can reach Bob on Signal at bobjherman.09.
Newsletter
Unpacking the business — and secretive inner workings — of the U.S. health care industry
